Strumento inattivo

Altre lingue Biosyent Inc. Toronto S.E.

Azioni

RX

CA0906901081

Altre lingue

BioSyent In-Licenses Endocrinology Product for Canada	12/06
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023.	17/05
BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	17/05
BioSyent Releases Financial Results for Q1 2024	17/05
BioSyent Declares Second Quarter 2024 Dividend	17/05
BioSyent Inc Declares Second Quarter 2024 Dividend, Payable June 15, 2024	17/05
BioSyent Schedules Q1 2024 Earnings Release for May 16, 2024	09/05
BioSyent to Attend Planet MicroCap Showcase	23/04
BioSyent Inc.(TSXV:RX) dropped from S&P/TSX Venture Composite Index	22/04
BioSyent Announces Extension of RepaGyn® and Proktis-M® Agreement	15/04
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference	10/04
FeraMAX® est la marque de supplément de fer que les pharmaciens et les médecins au Canada recommandent le plus souvent depuis neuf années consécutives	03/04
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year	03/04
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year	03/04
BioSyent To Present At LD Micro New York Investor Conference	01/04
BioSyent to Present at LD Micro New York Investor Conference	01/04
BioSyent Announces Grant of Restricted Share Units	27/03
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2022.	13/03
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023.	13/03
BioSyent Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Biosyent Inc. Toronto S.E.

Azioni

RX

CA0906901081

Altre lingue

Filtri